GlaxoSmithKline's Pharma Chief Lands Job at Chinese PE Firm Post author:Sam Post published:October 9, 2017 Post category:BioPharma October 10, 2017By Alex Keown, BioSpace.com Breaking News StaffBEIJING… Source: BioSpace You Might Also Like How This Little Biopharma Could Beat Amgen, Teva to the Migraine Finish Line January 16, 2018 <b>Trump</b> Budget Would Double FDA Product Review Fees, Leading to Faster Drug Approvals March 15, 2017 Mirati Therapeutics Reports Second Quarter 2017 Financial Results August 3, 2017
<b>Trump</b> Budget Would Double FDA Product Review Fees, Leading to Faster Drug Approvals March 15, 2017
